PLATINUM INVESTMENT MANAGEMENT LTD
Position in IDYA — IDEAYA Biosciences, Inc.
CIK 1256071
SYDNEY AUSTRALIA 2000, C3
Position in IDYA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,053,344
-$1,115,936 QoQ
Shares Held
91,637
-24.0% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PLATINUM INVESTMENT MANAGEMENT LTD holds $70,718,725 across 29 Biotechnology names. IDYA ranks #10 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
110,734 | $5,837,896 | |
| 2 | CNTA |
Centessa Pharmaceuticals plc
|
137,741 | $5,471,072 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
58,314 | $4,908,289 | |
| 4 | VERA |
Vera Therapeutics, Inc.
|
113,687 | $4,573,628 | |
| 5 | IMVT |
Immunovant, Inc.
|
181,774 | $4,515,266 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
112,066 | $4,313,420 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
64,752 | $4,059,950 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
49,269 | $3,658,715 |
All Filings in IDYA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,053,344 | 91,637 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,169,280 | 120,604 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,541,811 | 166,917 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,508,595 | 166,917 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $2,501,438 | 152,713 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,924,724 | 152,713 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,584,634 | 144,717 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $5,081,013 | 144,717 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,132,869 | 162,554 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $23,566,163 | 662,343 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $20,685,080 | 766,682 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $19,144,745 | 814,670 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $11,471,703 | 835,521 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $15,090,857 | 830,537 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,091,087 | 1,011,467 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,738,007 | 923,044 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $10,659,157 | 952,561 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $20,828,849 | 881,085 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $29,364,429 | 1,151,998 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $4,800,853 | 228,721 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $4,538,390 | 193,123 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,703,722 | 193,123 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,425,624 | 193,123 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||